Page 194 - Genentech News Today

Business Facilities Magazine highlights area economic development and site selection news from around the world.

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

Operator: Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode.

In this prospective, life-spanning, nationally representative cohort study, LRTI during early childhood was associated with almost a two times increased risk of premature adult death from respiratory disease, and accounted for one-fifth of these deaths.

For the first time in the history of the ISPE Facility of the Year Awards (FOYA) program, ISPE today announced the 2023 Facility of the Year Awards...

Also, the Lisa Dean Moseley Foundation gave $78 million for a new center in Delaware to improve clinical care for children with cancer or blood disorders, and 31 grantees will share $17 million from Genentech’s Health Equity and Diversity in STEM Innovation Fund.

SCOTTSDALE, Ariz. — The prevalence of systematic-onset juvenile idiopathic arthritis-related lung disease appears to be on the rise, and being aware of clinical manifestations is important for catching the disease early, a speaker said.

Yale Cancer Center is pleased to announce collaborative funding to support and increase access to early phase clinical trials for patients at community sites for cancer care in Connecticut.

Business Oregon leaders discuss how the state's post-pandemic economic rebound is fueled by manufacturing, services, and wholesale trade.

An email contained additional allegations about Marc Tessier-Lavigne’s Alzheimer’s research and the 2011 internal review that former colleagues allege uncovered falsification.